Simons Searchlight: September 2020 data release

New Simons Searchlight data were added to SFARI Base in September 2020.

Phenotypic data from the following individuals are now available for use by researchers studying autism or related neurodevelopmental conditions. More information about how to request access to this data is available here.

Copy number variants (CNVs):

322 carriers of the 16p11.2 deletion
(145 of these individuals were enrolled in Phase 1)

208 carriers of the 16p11.2 duplication
(130 of these individuals were enrolled in Phase 1)

72 carriers of the 1q21.1 deletion
(23 of these individuals were enrolled in Phase 1)
84 carriers of the 1q21.1 duplication
(27 of these individuals were enrolled in Phase 1)

12 carriers of the 7q11.23 duplication
(none of these individuals were enrolled in Phase 1)

Single genes (all individuals enrolled in Phase 2):

24 individuals with ADNP mutations
13 individuals with ANKRD11 mutations
13 individuals with ARID1B mutations
55 individuals with ASXL3 mutations
27 individuals with CHAMP1 mutations
10 individuals with CHD2 mutations
10 individuals with CHD8 mutations
28 individuals with CSNK2A1 mutations
44 individuals with CTNNB1 mutations
33 individuals with DYRK1A mutations
11 individuals with FOXP1 mutations
7 individuals with GRIN1 mutations
59 individuals with GRIN2B mutations
20 individuals with HIVEP2 mutations
24 individuals with HNRNPH2 mutations
5 individuals with MBD5 mutations
38 individuals with MED13L mutations
26 individuals with PACS1 mutations
6 individuals with PPP2R1A mutations
77 individuals with PPP2R5D mutations
5 individuals with PTCHD1 mutations
143 individuals with SCN2A mutations
32 individuals with SETBP1 mutations
5 individuals with SETD5 mutations
60 individuals with SLC6A1 mutations
95 individuals with STXBP1 mutations
50 individuals with SYNGAP1 mutations
6 individuals with TBR1 mutations
7 individuals with TRIP12 mutations

Detailed medical history and developmental and behavioral information (collected via clinical site visits) are available for families enrolled in Phase 1. Structural and functional magnetic resonance imaging (MRI) data and magnetoencephalography (MEG) data are available for many participants enrolled in Phase 1.

Medical, developmental and behavioral information (collected through online surveys and phone interviews with families) are available for families who are participating in Phase 2. Medical history interviews are updated with participants yearly.

Biospecimens, including cell lines (fibroblasts, lymphoblastoids and induced pluripotent stem cells) and DNA (derived from saliva, lymphoblastoids or whole blood), are available for many participants. A complete list of what is currently available can be found here. Enrollment in Simons Searchlight is ongoing, and additional data and biospecimens will be made available to researchers early next year.

Genetic data are available for many participants enrolled in Phase 1. Single nucleotide polymorphism (SNP) microarray data are available for 126 Phase 1 families (probands with 16p11.2 deletions/duplications, parents and siblings [if present]). Whole-exome sequencing (WES) data are available for 162 Phase 1 families (probands with 16p11.2 deletions/duplications, parents and siblings [if present]). Whole-genome sequencing (WGS) data are available for six carriers of the 16p11.2 deletion. Molecular inversion probe (MIP) sequencing data around the 16p11.2 rearrangement breakpoints are available for 78 carriers of the 16p11.2 deletion and 70 carriers of the 16p11.2 duplication.

Additional information

Publications resulting from Simons Searchlight data are available here (select the filter Uses Resources From: Simons Searchlight).
147 single genes and 20 CNVs that are known to be associated with autism and other neurodevelopmental conditions are being studied as part of Simons Searchlight. The complete gene/CNV list is available here.

Families interested in participating in Simons Searchlight can register online or can call (855) 329-5638 for more information.